Comment
Shahida N Syed, Marie J Ducrotoy, *Till T Bachmann
1
Division of Infection and Pathway Medicine, Edinburgh Medical School, University of Edinburgh, Edinburgh EH16 4SB, UK [email protected]
2
We declare no competing interests. The AMR DxC Autumn School 2015 received support from the following organisations: UK Medical Research Council, Scottish Universities Life Sciences Alliance, British Society for Antimicrobial Chemotherapy, Microbiology Society, Longitude Prize/Nesta, Edinburgh Infectious Diseases, Marks & Clerk, Global Health Academy of The University of Edinburgh. We acknowledge the contribution of the AMR DxC experts and speakers at the panel discussion of the AMR DxC Autumn School 2015: Gyorgy Abel (Lahey Hospital & Medical Center and Harvard Medical School, MA, USA), Abdul Ghafur (Apollo Hospital, Chennai, India), Ramanan Laxminarayan (Center for Disease Dynamics, Economics & Policy, Washington DC, USA), Dilip Nathwani (Ninewells Hospital and Medical School, Dundee, UK), Rosanna Peeling (London School of Hygiene and Tropical Medicine, London, UK), Jack Scannell (Innogen Institute, University of Edinburgh, Edinburgh, UK), and Penny Wilson (Innovate UK, London, UK).
3
4
Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2015; 16: 161–68. WHO. Global action plan on antimicrobial resistance. Geneva: World Health Organization, 2015. García-Álvarez L, Holden MTG, Lindsay H, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011; 11: 595–603. Nature. Mind meld (Editorial). Nature 2015; 525: 289–90.
Corrections Moore K A, Simpson J A, Pawet M K, et al. Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study. Lancet Infect Dis 2016; 16: 576–83—In figure 4, the footnote symbols in the legend should have read ‘*Hazard ratios are shown for treatments occurring before (
Shahida N Syed, Marie J Ducrotoy, *Till T Bachmann
1
Division of Infection and Pathway Medicine, Edinburgh Medical School, University of Edinburgh, Edinburgh EH16 4SB, UK [email protected]
2
We declare no competing interests. The AMR DxC Autumn School 2015 received support from the following organisations: UK Medical Research Council, Scottish Universities Life Sciences Alliance, British Society for Antimicrobial Chemotherapy, Microbiology Society, Longitude Prize/Nesta, Edinburgh Infectious Diseases, Marks & Clerk, Global Health Academy of The University of Edinburgh. We acknowledge the contribution of the AMR DxC experts and speakers at the panel discussion of the AMR DxC Autumn School 2015: Gyorgy Abel (Lahey Hospital & Medical Center and Harvard Medical School, MA, USA), Abdul Ghafur (Apollo Hospital, Chennai, India), Ramanan Laxminarayan (Center for Disease Dynamics, Economics & Policy, Washington DC, USA), Dilip Nathwani (Ninewells Hospital and Medical School, Dundee, UK), Rosanna Peeling (London School of Hygiene and Tropical Medicine, London, UK), Jack Scannell (Innogen Institute, University of Edinburgh, Edinburgh, UK), and Penny Wilson (Innovate UK, London, UK).
3
4
Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2015; 16: 161–68. WHO. Global action plan on antimicrobial resistance. Geneva: World Health Organization, 2015. García-Álvarez L, Holden MTG, Lindsay H, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011; 11: 595–603. Nature. Mind meld (Editorial). Nature 2015; 525: 289–90.
Corrections Moore K A, Simpson J A, Pawet M K, et al. Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study. Lancet Infect Dis 2016; 16: 576–83—In figure 4, the footnote symbols in the legend should have read ‘*Hazard ratios are shown for treatments occurring before (
